Albuquerque, NM, United States of America

Eric C Carnes

USPTO Granted Patents = 6 

Average Co-Inventor Count = 5.1

ph-index = 5

Forward Citations = 89(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Eric C. Carnes

Introduction

Eric C. Carnes is a notable inventor based in Albuquerque, NM (US). He has made significant contributions to the field of cancer treatment through his innovative inventions. With a total of 6 patents, his work focuses on developing advanced methods for targeted drug delivery.

Latest Patents

One of his latest patents is titled "Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same." This invention is directed towards creating protocells that specifically target hepatocellular and other cancer cells. The protocells comprise a nanoporous silica core with a supported lipid bilayer, along with agents that facilitate cancer cell death. These agents may include traditional small molecules, macromolecular cargo such as siRNA, or protein toxins. The invention also involves histone-packaged plasmid DNA that is disposed within the nanoporous silica core, which can be modified to assist in localizing protocells within the nucleus of cancer cells. The targeted delivery system aims to enhance the specificity of binding to cancer cells, promoting effective treatment and diagnosis of cancer.

Career Highlights

Throughout his career, Eric has worked with reputable organizations such as Stc.unm and Sandia Corporation. His experience in these companies has contributed to his expertise in the field of cancer research and drug delivery systems.

Collaborations

Eric has collaborated with notable colleagues, including Carlee Erin Ashley and C. Jeffrey Brinker. These collaborations have further enriched his research and development efforts in innovative cancer treatment solutions.

Conclusion

Eric C. Carnes is a distinguished inventor whose work in developing protocells for targeted cancer treatment showcases his commitment to advancing medical technology. His contributions are paving the way for more effective cancer therapies and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…